期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

ω-3多不饱和脂肪酸对结直肠癌患者的营养治疗作用 被引量：4

暂未订购
导出
摘要 目的研究ω-3多不饱和脂肪酸对结直肠癌患者的营养治疗作用。方法将晚期结直肠癌患者63例随机分为两组:研究组32例,静脉输注中长链脂肪乳0.9 g/(kg.d)和ω-3多不饱和脂肪酸0.1g/(kg.d);对照组31例,输注中长链脂肪乳1 g/(kg.d),观察治疗前后的白蛋白、C反应蛋白和KPS评分值变化和不良反应。结果 7 d后,两组白蛋白值有增加趋势,但差异无统计学意义(P>0.05)。治疗后,研究组与对照组比较,C反应蛋白值降低,KPS评分值增加,差异有统计学意义(P<0.05)。结论加用ω-3多不饱和脂肪酸能降低结直肠癌患者外周血CRP水平和增加KPS评分值,无明显不良反应,是便捷有效的营养治疗方法。
作者 高炜 杨建伟 陈帆 陈奕贵
机构地区 福建省肿瘤医院肿瘤内科
出处 《广东医学》 CAS CSCD 北大核心 2011年第16期2097-2098,共2页 Guangdong Medical Journal
关键词 结直肠肿瘤 营养治疗 Ω-3多不饱和脂肪酸 C反应蛋白 免疫调理
分类号 R442.8 [医药卫生—诊断学]
  • 相关文献

参考文献9

  • 1AUGUST D A, HUHMANN M B. American Society for Parenteral and Enteral Nutrition (A. S. P. E. N. ) Board of Directors. A. S. P. E. N. clinical guidelines: nutrition support therapy during adult anticancer treatment and in hematopoietic cell transplantation [J]. JPEN J Parenter Enteral Nutr, 2009, 33(5) : 472 -500.
  • 2KONDRUP J, RASMUSSEN H H, HAMBERG O, et al. Nutritional risk screening ( NRS 2002 ) : a new method based on an a- nalysis of control - led clinical trials [ J]. Clin Nutr, 2003, 22(4) : 321 -336.
  • 3MARK H. DeLegge Nutrition and Gastrointestinal Disease [ M ].丁连安,译.北京:人民卫生出版社,2010:98-109.
  • 4江志伟,张佃良,于宝军,李宁,黎介寿.肿瘤坏死因子基因多态性与癌性恶液质相关性研究[J].中国实用外科杂志,2003,23(5):301-303. 被引量：8
  • 5BLAKWILL F, MANTOVANI A. Inflammation and cancer: back to virchow[J]. Lancet, 2001, 357(9255) : 539 -545.
  • 6CASTELI, J V, GOMEZ LECHONMJ, DAVID M, et al. Acute- phase response of human hepatocytes: regulation of acute - phase protein synthesis by Intedeukin - 6[J].Hepatology, 1990, 12 (5): 1179 -1186.
  • 7SHIU Y C, LIN J K, HUANG C J, et al. Is C - reactive protein a prognostic factor of colorectal cancer? [ J ]. Diseases Colon Rectum, 2008, 51 (4) : 443 - 449.
  • 8NIELSEN H J, CHRISTENSEN I J, SORENSEN S, et al. Preoperative plasma plasminogen activator inhibitor type - I and set, am c -reaetive protein levels in patients with eolnrectal cancer [ J ]. Ann Surg Oncol, 2000, 7(8) : 617 -623.
  • 9TASHIRO T. N - 3 polyunsaturated fatty acids in pharmaconutrition and immmunonutrition[J].J Gastroenterol, 2000, 35 ( Suppl 12) : 24.

二级参考文献9

  • 1Bruera E. ABC of palliative care. Anorexia,cachexia and nutrition.Br Med J,1997,315(7117) :1219.
  • 2Tisdale MJ. Biomedicine. Protein Loss in Cancer Cachexia. Science,2000,289(5488) .2293.
  • 3Wilson AG, Symons JA, McDowell TL, et al. Effects of a polymorphism in the human tumor necrosis factor α promoter on transcriptional activation. Proc Natl Acad Sci USA, 1997,94 ( 7 ) : 3195.
  • 4Kroeger KM, Carville KS, Abraham IJ. The - 308 tumor necrosis factor-alpha promoter polymorphism effects transcription. Mol Immunol, 1997,34(5) :391.
  • 5Nelson KA. The cancer anorexia-cachexia syndrome. Semin Oncol,2000,27(1) :64.
  • 6Bossola M, Muscaritoll M, Bellantone R, et al. Selma tumor necrosis factor-α levels in cancer patients are discontinuous and correlate　with weight loes. Eur J Clin Invest,2000,30(12) :1107.
  • 7Wu CW,Chi CW,Hsieh MC,et al. Tumor necrosis factor in patients with gastric cancer. Anticancer Res,1998,18(3A) :1597.
  • 8Nakashima J, Tachibana M, Ueno M, et al. Association between tumor necrosis factor in serum and cachexia in patients with prostatecancer. Clin Cancer Res,1998,4(7) :1743.
  • 9Tarkowski E,Liljeroth AM,Nilsson A,et al. TNF gene ploymorphism and its relation to intracerebral production of TNFα and TNFβ in　AD. Neurology,2000,54 ( 11 ) :2077.

共引文献7

同被引文献88

  • 1Brenna JT, Salem J rN, Sinclair AJ, et al. Alpha - linolenic acid sup- plementation and conversion to n - 3 long - chain polyunsaturated fatty acids in humans[J]. Prostaglandins Leukot Essent Fatty Acids,2009,80(2) :85 - 91.
  • 2Arterburn LM, Hall EB, Oken H. Distribution, intereonversion, and dose response of n - 3 fatty acids in humans[J]. Am J Clin Nutr,2006,83(6) ;1467 - 1476.
  • 3Rachel S,Rosemary AK. Molecular mechanisms of harma eonutri- ents[J]. Journal of Surgical Research, 2010,161 (2) : 288 - 294.
  • 4Barry AM. Immunonutrition and critical illness:An update[J]. Nu trition,2010,26(7/8) :701 - 707.
  • 5Bernabe - Garcia M, Lopez - Alarc6n M, Blaneo - Favela F, et al. Beneficial effects of the n - 3 long chain polyunsaturated fatty acids in surgical patients: Updating the evidence[J]. Prostaglandins Leu- kot Essent Fatty Acids,2011,85(5): 261 -266.
  • 6Hector LL. Nutritional interventions to prevent and treat osteoar- thritis. Part IFocus on fatty acids and macronutrients[J]. Osteo- arthritis Supplement,2012(4) :S145 -S154.
  • 7Carl JL, Richard VM, Mandeep RM, et al. Omega - 3 polyunsatu- rated fatty acids and cardiovascular diseases[J]. J Am Coll Cardiol, 2009,54(7) :585 - 594.
  • 8Anand RG,Alkadri M,Lavie CJ,et al. The role of fish oil in ar rhythmia prevention[J]. J Cardiopulm Rehabil Prev, 2008,28 (2) : 92 - 98.
  • 9Joensen AM, Schmidt EB, Dethlefsen C, et al. Dietary intake of total marine n - 3 polyunsaturated fatty acids, eicosapentaenoic acid,doeosahexaenoic acid and docosapentaenoic acicl and the risk of acute coronary syndrome-a cohort study[J]. Br J Nutr,2010, 103(4) :602 - 607.
  • 10Lavie CJ, MiIani RV, Mehra MR, et al. Omega - 3 polyunsaturat- ed fatty acids and cardiovascular diseases[J]. J Am Coil Cardiol, 2009,54(7) :585- 594.

引证文献4

二级引证文献21

广东医学
2011年 第16期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部